These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26282678)

  • 1. Harmful somatic amino acid substitutions affect key pathways in cancers.
    Niroula A; Vihinen M
    BMC Med Genomics; 2015 Aug; 8():53. PubMed ID: 26282678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large differences in proportions of harmful and benign amino acid substitutions between proteins and diseases.
    Schaafsma GCP; Vihinen M
    Hum Mutat; 2017 Jul; 38(7):839-848. PubMed ID: 28444810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional synergies yet distinct modulators affected by genetic alterations in common human cancers.
    Bessarabova M; Pustovalova O; Shi W; Serebriyskaya T; Ishkin A; Polyak K; Velculescu VE; Nikolskaya T; Nikolsky Y
    Cancer Res; 2011 May; 71(10):3471-81. PubMed ID: 21398405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PASE: a novel method for functional prediction of amino acid substitutions based on physicochemical properties.
    Li X; Kierczak M; Shen X; Ahsan M; Carlborg O; Marklund S
    Front Genet; 2013; 4():21. PubMed ID: 23508070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CanProVar 2.0: An Updated Database of Human Cancer Proteome Variation.
    Zhang M; Wang B; Xu J; Wang X; Xie L; Zhang B; Li Y; Li J
    J Proteome Res; 2017 Feb; 16(2):421-432. PubMed ID: 27977206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways.
    Gu Y; Zhao W; Xia J; Zhang Y; Wu R; Wang C; Guo Z
    Hum Mutat; 2011 Sep; 32(9):1028-35. PubMed ID: 21618647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying gene selection in cancer through protein functional alteration bias.
    Brandes N; Linial N; Linial M
    Nucleic Acids Res; 2019 Jul; 47(13):6642-6655. PubMed ID: 31334812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the functional consequences of somatic missense mutations found in tumors.
    Carter H; Karchin R
    Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
    Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
    Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Algorithms for detecting significantly mutated pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    J Comput Biol; 2011 Mar; 18(3):507-22. PubMed ID: 21385051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial patterns of somatic gene mutations in cancer.
    Yeang CH; McCormick F; Levine A
    FASEB J; 2008 Aug; 22(8):2605-22. PubMed ID: 18434431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers.
    Heim D; Budczies J; Stenzinger A; Treue D; Hufnagl P; Denkert C; Dietel M; Klauschen F
    Int J Cancer; 2014 Nov; 135(10):2362-9. PubMed ID: 24706491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of a cancer somatic mutome.
    Hernández P; Solé X; Valls J; Moreno V; Capellá G; Urruticoechea A; Pujana MA
    Mol Cancer; 2007 Feb; 6():13. PubMed ID: 17280605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a cancer type-specific distribution for consecutive somatic mutation distances.
    Muiño JM; Kuruoğlu EE; Arndt PF
    Comput Biol Chem; 2014 Dec; 53 Pt A():79-83. PubMed ID: 25179009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis.
    Savas S; Kim DY; Ahmad MF; Shariff M; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):801-7. PubMed ID: 15159313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
    Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
    Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.